Table 3.
Status of proteasomal activity in different cancer types
| Cancer type | Cancer cell type | Status of proteasomal activity | References | |
|---|---|---|---|---|
| Increased proteasomal activity | Reduced proteasomal activity | |||
| Bladder cancer | Human bladder cancer cells; human T24 urinary bladder carcinoma cell line | X | [75–77] | |
| Brain tumor | GBM stem-like cells; temozolomide-resistant glioma cell lines | X | [104] | |
| Breast cancer | MCF-7 and MDA-MB-231 human breast cancer cells | X | [78] | |
| Cancer stem cells | Various cancer stem cells; human head and neck squamous cell carcinoma (HNSCC) cells; breast cancer stem cells (BCSCs) | X | [98–103] | |
| Colon cancer | HCT116 colon adenocarcinoma cells; metastatic colorectal cancer tissue | X | [79, 80] | |
| Lung cancer | Lung cancer cell lines (H460, A549 and H129) | X | [81, 82] | |
| Skin cancer | Various human and mouse tumor cell lines | X | [84] | |
| Ovarian cancer | Various ovarian cancer cell lines | X | [83] | |
| Pancreatic cancer | MIA-PaCa-2 human pancreatic cancer cells | X | [85] | |
| Prostate cancer | LNCaP (AD) and PC3 (AI) PCa cells | X | [86] | |
| Renal cancer | Renal cell carcinoma tissue; clear cell renal cell carcinoma (CCRCC) cell lines | X | [87–89] | |